Person

Robert J. Palmisano

Healthcare executive with over 40 years of experience leading global medical technology companies. Served as President and CEO of Wright Medical Group N.V. from 2011 until its acquisition by Stryker Corporation in 2020 for approximately $4.7 billion. Previously CEO of ev3 Inc.

(acquired by Covidien for $2.6B in 2010), IntraLase Corp. (IPO 2004, acquired by Advanced Medical Optics 2007), MacroChem Corporation, and Summit Technology (acquired by Alcon 2000). Chairman and CEO of Priveterra Acquisition Corporation since 2020. Providence College alumnus (class of 1966).

American

Track Robert J. Palmisano

Machine-readable surfaces

Markdown mirror: /people/robert-palmisano.md
JSON-LD: embedded in this page’s head
REST API: /v1/people/robert-palmisano
Revision history: /people/robert-palmisano/history
Data documentation: /data
Query this programmatically: Deploy MCP

76faf826-2be2-463e-b787-67a4ad8b2b4e

Former / Previously (1)

Wright Medical Group President and CEOSecondary-verified

Sources (3)

Deploy Watch

Track Robert J. Palmisano on Deploy.

We notify you when a verified role changes, a founded-company event lands, or litigation surfaces.